SENTREX BIOSPONGE MPD— 510(k) K123961

Name: FDA 510(k) clearance K123961
Creator: U.S. Food and Drug Administration
Published: 2013-04-05

Substantially Equivalent

Bionova Medical, Inc.

FDA 510(k) clearance K123961 for SENTREX BIOSPONGE MPD, Substantially Equivalent on 2013-04-05. Applicant: Bionova Medical, Inc.. Device class: Unclassified.

Clearance details

Applicant: Bionova Medical, Inc.
Product code: Code KGN
Device class: Unclassified
Advisory panel: Unknown
Date received: 2012-12-26
Decision date: 2013-04-05
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Germantown, TN, US

Download summary PDF View on FDA.gov ↗

Recent devices under product code KGN

view all

K260652 — ColActive Plus2026-09-09
K260711 — Accelagen Plus Surgical Matrix, 1cc (CG-01AP) +4 more2026-08-27
K260596 — Collagen Wound Powder2026-07-02
K260669 — Endoform Dermal Template2026-06-24
K253521 — ECMT-100 WMD2026-06-18

More clearances from Bionova Medical, Inc.

view all

K243181 — Foundation Dermal Regeneration Scaffold Plus (DRS+) Solo2024-10-31
K240298 — Foundation Dermal Regeneration Scaffold Plus (DRS+) Duo2024-08-21
K231937 — Foundation Dermal Regeneration Scaffold (DRS) Solo2023-11-13
K210949 — Foundation Dermal Regeneration Scaffold (DRS) Solo2022-08-11
K112191 — HEALEX BIOSPONGE WOUND DRESSING2012-06-05

Adverse events under product code KGN

product code KGN

Other: 2
Total: 2

Source: openFDA MAUDE database, 2020-01-01 through 2026-04-23. Counts aggregate all devices under this product code, not just this specific clearance. Reports are submissions to FDA, not validated events. Search MAUDE directly →

Data sourced from openFDA. This site is unofficial and independent of the FDA.